Skip to content

In this installment of "Aspirin for prevention," physician-researcher Randall Stafford provides tips to calculate the risk of heart disease or stroke, to inform decisions about taking aspirin preventatively.

In this installment of "Aspirin for prevention," physician-researcher Randall Stafford provides tips to calculate the risk of heart disease or stroke, to inform decisions about taking aspirin preventatively.

A team of Stanford physicians explains why research has found that taking aspirin to prevent cardiovascular disease may be riskier than previously thought.

A team of Stanford physicians explains why research has found that taking aspirin to prevent cardiovascular disease may be riskier than previously thought.

Published on

Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.

Many metastatic colorectal cancers appear "born to be bad," spreading to other organs before any diagnosis has been made, say Stanford researchers.

Stanford geneticists discuss the future of genomics, including the importance of studying diverse populations for medical research.

Stanford geneticists discuss the future of genomics, including the importance of studying diverse populations for medical research.

Stanford psychologist Ian Gotlib is examining how depression develops and working to identify potential opportunities for intervention.

Stanford psychologist Ian Gotlib is examining how depression develops and working to identify potential opportunities for intervention.

Published on

Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.

Decision scientist Mehlika Toy is working with the WHO to help eliminate the public health burden of hepatitis B by the year 2030.

The U.S. Preventive Services Task Force is now recommending that men aged 55 to 69 should talk with their doctors about prostate-specific antigen screening.

The U.S. Preventive Services Task Force is now recommending that men aged 55 to 69 should talk with their doctors about prostate-specific antigen screening.